Adenosine Deaminase Deficiency News and Research

RSS
Adenosine deaminase (ADA) deficiency is an inherited disorder that damages the immune system and causes severe combined immunodeficiency (SCID). Children with SCID lack virtually all immune protection from bacteria, viruses, and fungi. They are prone to repeated and persistent infections that can be very serious or life-threatening. These infections are often caused by "opportunistic" organisms that ordinarily do not cause illness in people with a normal immune system. Infants with SCID typically experience pneumonia, chronic diarrhea, and widespread skin rashes, and grow much more slowly than healthy children. Some also have neurological problems such as developmental delay, movement disorders, and hearing loss. If not treated in a way that restores immune function, children with SCID usually live only a year or two.
BioLife reports increased use of CryoStor and HypoThermosol biopreservation media products in clinical studies

BioLife reports increased use of CryoStor and HypoThermosol biopreservation media products in clinical studies

Orphan, St George's sign licensing agreement to develop new therapies for metabolic disorders

Orphan, St George's sign licensing agreement to develop new therapies for metabolic disorders

Gene therapy can effectively treat ADA-deficient severe combined immunodeficiency

Gene therapy can effectively treat ADA-deficient severe combined immunodeficiency

Global gene therapy market to reach $300 million by 2015

Global gene therapy market to reach $300 million by 2015

Children's Hospital pediatric immunologist collaborates with European gene therapy researchers to study WAS syndrome

Children's Hospital pediatric immunologist collaborates with European gene therapy researchers to study WAS syndrome

Adult human stem cells shown not to pose a cancer risk when implanted into different organs

Adult human stem cells shown not to pose a cancer risk when implanted into different organs